{"nct_id":"NCT04059484","title":"Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2019-10-22","start_date_type":"ACTUAL","primary_completion_date":"2022-02-15","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}